dihexa lipophilic peptidomimetic Peptidomimetics based on thiacalixarene with L-tyrosine moieties: Antibacterial activity against methicillin-resistant Staphylococcus aureus and degradation induced by binding to α-chymotrypsin Peptidomimetics, a synthetic tool of

SIRT1 enhances synaptic formation and synaptic activity, and therefore, can reduce the progression of various degenerative brain diseases including Parkinsons disease (PD)

No injections

Foundational research is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Healths PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed studies on GHK-Cu cellular biology and copper-binding peptide research

Some protocols recommend even lower starting doses around 0.05 mg (50 mcg) for particularly sensitive individuals, though most users find 0.1 mg an appropriate beginning point

Despite its light and gentle formula, the product effectively regenerates the skin, providing it with essential active ingredients

Concentrations below 12-15% in leave-on cosmetics is generally well-tolerated